Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
987
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Chantana Polpraserta Faculty of Medicine, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6949-4449View further author information
ORCID Icon,
Pimjai Niparuckc Faculty of Medicine, Department of Medicine, Mahidol University Ramathibodi Hospital, Bangkok, ThailandView further author information
,
Thanawat Rattanathammetheed Faculty of Medicine, Department of Internal Medicine, Chiang Mai University, Chiang Mai, ThailandView further author information
,
Sirorat Kobbuakleea Faculty of Medicine, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
,
Theerin Lanamtienge Faculty of Medicine, Department of Medicine, Khon Kaen University, Khon Kaen, ThailandView further author information
&
Ponlapat Rojnuckarina Faculty of Medicine, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;b Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, ThailandView further author information
Pages 1301-1304 | Received 15 Sep 2022, Accepted 20 Nov 2022, Published online: 15 Dec 2022

References

  • Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–2465.
  • Nazha A, Narkhede M, Radivoyevitch T, et al. Incorporation of molecular data into the revised international prognostic scoring system in treated patients with myelodysplastic syndromes. Leukemia. 2016;30:2214–2220.
  • Bernard E TH, Greenberg PL, Hasserjian RP, et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM EVID. 2022;1:1–14.
  • Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–1719.
  • Ferrone C, Wong H, Semenuk L, et al. Validation and clinical impact of the Oncomine myeloid targeted DNA and RNA ion semiconductor sequencing assay. Blood. 2018;132:5523.
  • Atli EI, Gurkan H, Atli E, et al. The importance of targeted next-generation sequencing usage in cytogenetically Normal myeloid malignancies. Mediterr J Hematol Infect Dis. 2021;13:e2021013.
  • Greenberg PL, Stone RM, Al-Kali A, et al. NCCN guidelines(R) insights: myelodysplastic syndromes, version 3. 2022. J Natl Compr Canc Netw. 2022;20:106–117.
  • Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122:3616–3627; quiz 99.
  • Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med. 2012;366:1079–1089.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.